Yet, statin-mediated activation of the transcriptional network of the cholesterol feedback control is probably responsible for the elevation of ACE2 levels [145,146] (Figure 3), thereby reducing the risk of vasoconstriction, inflammation, oedema and fibrosis that contribute to COVID-19 severity [147,148]. This evidence concerns the gene ACE2 and COVID-19.